April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to an issue called ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
-
-
April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of rupturing were far less likely to suffer a serious cardiac event if they underwent ...
-
April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to ...
-
April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second heart attack among people with normal heart pumping ability, as indicated by an ...
April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...
April 15, 2024
April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...
April 12, 2024
April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...
April 11, 2024Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...
April 11, 2024
April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...
April 10, 2024
April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...
April 09, 2024
April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...
April 08, 2024
April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...
April 08, 2024
April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart ...
April 07, 2024
April 6, 2024 — Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did ...
April 06, 2024
EMPACT-MI Trial Outcomes Reported at ACC.24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack
April 6, 2024 — Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did ...
April 06, 2024
April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...
April 05, 2024
April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...
April 05, 2024
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com:
1. CLS Health ...
April 04, 2024
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...
April 02, 2024© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now